Shi B - Search Results

1

SMARCC1 Enters the Nucleus via KPNA2 and Plays an Oncogenic Role in Bladder Cancer.

Wei Z, Xu J, Li W, Ou L, Zhou Y, Wang Y, Shi B. Wei Z, et al. Among authors: shi b. Front Mol Biosci. 2022 May 20;9:902220. doi: 10.3389/fmolb.2022.902220. eCollection 2022. Front Mol Biosci. 2022. PMID: 35669562 Free PMC article.

2

Aberrant expression of KPNA2 is associated with a poor prognosis and contributes to OCT4 nuclear transportation in bladder cancer.

Zhou J, Dong D, Cheng R, Wang Y, Jiang S, Zhu Y, Fan L, Mao X, Gui Y, Li Z, Li X, Shi B. Zhou J, et al. Among authors: shi b. Oncotarget. 2016 Nov 8;7(45):72767-72776. doi: 10.18632/oncotarget.11889. Oncotarget. 2016. PMID: 27611951 Free PMC article.

3

FAM64A is an androgen receptor-regulated feedback tumor promoter in prostate cancer.

Zhou Y, Ou L, Xu J, Yuan H, Luo J, Shi B, Li X, Yang S, Wang Y. Zhou Y, et al. Among authors: shi b. Cell Death Dis. 2021 Jul 2;12(7):668. doi: 10.1038/s41419-021-03933-z. Cell Death Dis. 2021. PMID: 34215720 Free PMC article.

4

FAM107A as a Tumor Suppressor in Bladder Cancer Inhibits Cell Proliferation, Migration, and Invasion.

Ou L, Wei Z, Xu J, Li W, Zhou Y, Wang Y, Shi B. Ou L, et al. Among authors: shi b. Ann Clin Lab Sci. 2022 Mar;52(2):260-268. Ann Clin Lab Sci. 2022. PMID: 35414505

5

ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway.

Xu J, Wang Y, Jiang J, Yin C, Shi B. Xu J, et al. Among authors: shi b. J Transl Med. 2023 Jan 30;21(1):56. doi: 10.1186/s12967-023-03913-1. J Transl Med. 2023. PMID: 36717944 Free PMC article.

6

Renal pseudoaneurysm after holmium laser lithotripsy with flexible ureteroscopy: an unusual case report and literature review.

Yin C, Chen F, Jiang J, Xu J, Shi B. Yin C, et al. Among authors: shi b. J Int Med Res. 2023 Mar;51(3):3000605231162784. doi: 10.1177/03000605231162784. J Int Med Res. 2023. PMID: 36974990 Free PMC article. Review.

7

Identification of ATP6V0A4 as a potential biomarker in renal cell carcinoma using integrated bioinformatics analysis.

Xu J, Jiang J, Yin C, Wang Y, Shi B. Xu J, et al. Among authors: shi b. Oncol Lett. 2023 Jul 11;26(3):366. doi: 10.3892/ol.2023.13952. eCollection 2023 Sep. Oncol Lett. 2023. PMID: 37559594 Free PMC article.

8

Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7.

Su B, Zhao W, Shi B, Zhang Z, Yu X, Xie F, Guo Z, Zhang X, Liu J, Shen Q, Wang J, Li X, Zhang Z, Zhou L. Su B, et al. Among authors: shi b. Mol Cancer. 2014 Sep 6;13:206. doi: 10.1186/1476-4598-13-206. Mol Cancer. 2014. PMID: 25193015 Free PMC article.

9

High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.

Shi B, Su B, Fang D, Tang Y, Xiong G, Guo Z, He Q, Yang X, Zhao W, Guo Y, Li X, Zhou L. Shi B, et al. BMC Cancer. 2015 May 9;15:380. doi: 10.1186/s12885-015-1369-8. BMC Cancer. 2015. PMID: 25956057 Free PMC article.

10

Editorial Expression of Concern: Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7.

Su B, Zhao W, Shi B, Zhang Z, Yu X, Xie F, Guo Z, Zhang X, Liu J, Shen Q, Wang J, Li X, Zhang Z, Zhou L. Su B, et al. Among authors: shi b. Mol Cancer. 2023 Apr 26;22(1):74. doi: 10.1186/s12943-023-01778-y. Mol Cancer. 2023. PMID: 37101172 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,600 results

Search Page

Filters